Search Results - Marja Dubay
- Showing 1 - 3 results of 3
-
1
Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay by Claire Bonfils, Ann Kalita, Marja Dubay, Lillian L. Siu, Michael A. Carducci, Gregory K. Reid, Robert E. Martell, Jeffrey M. Besterman, Zuomei Li
Published 2008Artigo -
2
Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia by Kristie A. Blum, Anjani Advani, Louis A. Fernandez, Richard van der Jagt, Joseph Brandwein, Suman Kambhampati, Jeannine Kassis, Melanie E. Davis, Claire Bonfils, Marja Dubay, Julie Dumouchel, Michel Drouin, David Lucas, Robert E. Martell, John C. Byrd
Published 2009Artigo -
3
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia by Guillermo Garcia‐Manero, Sarit Assouline, Jorge E. Cortés, Zeev Estrov, Hagop M. Kantarjian, Hui Yang, Willie Newsome, Wilson H. Miller, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, T. Patterson, Zuomei Li, Jeffrey M. Besterman, Gregory K. Reid, Eric Laille, Robert E. Martell, Mark D. Minden
Published 2008Artigo
Search Tools:
Related Subjects
Biochemistry
Gene
Histone
Histone deacetylase
Histone deacetylase inhibitor
Medicine
Pharmacokinetics
Pharmacology
Biology
Chemistry
Gastroenterology
Internal medicine
Leukemia
Oncology
Acetylation
Adverse effect
Astrobiology
Biotechnology
Cancer research
Chemotherapy
Chronic lymphocytic leukemia
Concomitant
Cyclophosphamide
Ex vivo
Fludarabine
In vitro
In vivo
Lymphoma
Molecular biology
Nausea